Phase II trial with 5-fluorouracil and high-dose folinic acid, using new sequential dosing schedule, in pretreated advanced breast cancer patients.

Zola, P; Bergamino, T; Katsaros, D; Ferrero, A; Ciancio, A; Bellora, G; Sismondi, P

Zola, P; Bergamino, T; Katsaros, D; Ferrero, A; Ciancio, A; Bellora, G; Sismondi, P.

Affiliation

Zola P; Dept. Gynecologic Oncology, University of Turin.

Eur J Gynaecol Oncol ; 13(6): 527-32, 1992.

Article in En | MEDLINE | ID: mdl-1473534

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Bone Neoplasms/secondary; Doxorubicin/administration & dosage; Drug Administration Schedule; Female; Fluorouracil/administration & dosage; Follow-Up Studies; Humans; Leucovorin/administration & dosage; Middle Aged; Remission Induction; Skin Neoplasms/secondary

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Eur J Gynaecol Oncol Year: 1992 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links